Medical information Clinical review pending

Infection Testing

Metapneumonia Virus A B Detection and Differentiation RNA Detection Qualitative Test

Detects the presence of Metapneumonia Virus A and B RNA using Real Time PCR. This test helps diagnose respiratory infections caused by these viruses, especially important for children and those with weakened immune systems.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Bronchial Swab, Bronchial Lavage, Sputum, Nasopharyngeal aspirates and swabs in viral transport medium, or lung tissues.
Results: Confirm with the laboratory before booking.
Preparation: No specific patient preparation is required. Ensure the sample collection is performed correctly by a trained healthcare professional. Confirm with the laboratory before booking.

Test priceKSh 18,700

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Metapneumonia Virus A B Detection and Differentiation RNA Detection Qualitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Symptoms of respiratory infection (cough, wheezing, difficulty breathing)
✓Diagnosis of pneumonia or bronchiolitis
✓Epidemiological investigations of respiratory outbreaks
✓Patients with weakened immune systems
✓Children with severe respiratory illness
✓Monitoring treatment response

In plain language

What this test helps you understand

This test helps identify the specific Metapneumonia virus (A or B) causing a respiratory infection. Accurate diagnosis allows healthcare providers to implement appropriate management strategies, potentially reducing the severity of illness and preventing further spread.

The Metapneumonia Virus A B Detection and Differentiation RNA Detection Qualitative Test is a diagnostic tool used to identify infections caused by Metapneumonia viruses. These viruses are a common cause of respiratory illnesses, particularly in young children and individuals with compromised immune systems. Early and accurate diagnosis is important for managing the illness effectively.

This test specifically looks for the genetic material (RNA) of both Metapneumonia Virus A and B. It uses a sensitive technique called Real Time PCR (Polymerase Chain Reaction) to detect even small amounts of the virus in a sample.

If you are experiencing symptoms like cough, wheezing, or difficulty breathing, or if you have been exposed to someone with a respiratory infection, this test may be recommended by your doctor. It can help determine if Metapneumonia virus is the cause of your symptoms, guiding appropriate treatment and care.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo specific patient preparation is required. Ensure the sample collection is performed correctly by a trained healthcare professional. Confirm with the laboratory before booking.

SampleBronchial Swab, Bronchial Lavage, Sputum, Nasopharyngeal aspirates and swabs in viral transport medium, or lung tissues.

MethodologyReal Time PCR (Polymerase Chain Reaction)

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test detects the presence of viral RNA but does not quantify the viral load. A negative result does not completely rule out infection, especially if the sample was collected late in the illness or improperly. False positives can occur due to contamination. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

Metapneumonia virus is a common respiratory virus that can cause illnesses ranging from mild cold-like symptoms to severe pneumonia, especially in young children and older adults.

Identifying the specific virus causing respiratory illness helps doctors provide the most appropriate care and manage potential complications. It also aids in controlling the spread of infection.

The test requires a sample from the respiratory tract, such as a nasal swab, throat swab, sputum, or bronchial lavage fluid. Your doctor will determine the best sample type.

Turnaround time varies. Please confirm the current estimated turnaround time with the laboratory before booking your test.

A positive result indicates that the RNA of Metapneumonia Virus A or B was detected in your sample, suggesting an active infection. Your doctor will interpret this result in the context of your symptoms and medical history.

Insurance coverage varies. Please check with your insurance provider regarding coverage for this specific test.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp